
Time
|
Topic
|
Speaker
|
Friday, 7 June 2024 (Day 1)
|
12:40 pm - 1 pm
|
Chronic Lymphocytic Leukemia Updates: What Can You Change in One Year?
By Janssen
|
Prof. Martin Trepel
Germany
|
2:55 pm - 3:15 pm
|
Rituximab in Non-Hodgkin’s Lymphoma: How the Biosimilar Could Do Better?
By Sandoz
|
Dr. Antonio Salar
Spain
|
5:40 pm - 6 pm
|
Relapsed/Refractory Multiple Myeloma: Overview and Future Landscape
By Pfizer
|
Dr. Faraz Khan
United Arab Emirates
|
Saturday, 8 June 2024 (Day 2)
|
12:20 pm - 12:40 pm
|
Chronic Myeloid Leukemia Uncovered: Unmet Needs & Potential of Novel Therapeutics
By
Novartis
|
Prof. Valentin Garcia
Spain
|
3:40 pm - 4 pm
|
New Hope in 3rd Line Diffuse Large B-Cell Lymphoma Management
By
AbbVie
|
Dr. David Lewis
United Kingdom
|